Burjeel mammography truck targets women 40+ across Abu Dhabi in October

Burjeel Cancer Institute has launched a mobile mammography campaign across Abu Dhabi, Al Ain and surrounding areas for Breast Cancer Awareness Month, bringing screening closer to women aged 40 and above.

The operational lesson reaches beyond Abu Dhabi. In Dubai, the Dubai Health Authority (DHA) periodic screening guideline recommends a breast cancer mammogram every 2 years from age 40. In Abu Dhabi, the Department of Health Abu Dhabi (DOH) and the Abu Dhabi Public Health Centre (ADPHC) back early detection programmes. In the northern emirates, the Ministry of Health and Prevention (MOHAP) is the relevant regulator for licensed private facilities.

What Burjeel is doing

Burjeel said on 30 September 2026 that the mobile mammography truck will visit dozens of locations across Abu Dhabi, including government entities, private-sector workplaces, schools, malls, residential communities and locations in Al Ain. Named stops include Daman, Etihad Airways, TAQA Distribution, ADNOC in Al Ain, Umm Al Emarat Park, Deerfields Mall, Khalifa Port and KEZAD, according to Burjeel's announcement.

The campaign is supported by DOH Abu Dhabi and ADPHC. Burjeel also said DOH Abu Dhabi recently designated Burjeel Cancer Institute as a Center of Excellence for breast cancer. That matters for referral managers because a screening campaign creates downstream demand for diagnostic imaging, biopsy, breast surgery, medical oncology and radiotherapy appointments.

"Early detection is one of the most important tools we have in the fight against breast cancer." Prof. Humaid Al Shamsi, Chief Executive Officer, Burjeel Cancer Institute

Burjeel said mammograms will be conducted under the supervision of a specialised medical and technical team. It has not published a single public price for the 2026 truck campaign in the announcement. Patients and HR teams should confirm the exact fee, appointment rules, eligibility and insurance pre-authorisation before sending staff to a screening day.

Why clinics and insurers should care

For clinic COOs, mobile screening changes the bottleneck. The mammogram is a short procedure, but abnormal findings need fast routing into ultrasound, diagnostic mammography, biopsy and specialist review. Mediclinic lists a screening mammogram at AED 375 and mammogram plus breast ultrasound at AED 725, with results shared within 15 working days. Cleveland Clinic Abu Dhabi lists a self-pay breast cancer screening package from AED 1,700. Emirates Hospitals Group lists a Dubai mammogram package at AED 300. These published prices show the cash-pay spread that insurers and employers will face when campaigns convert awareness into bookings.

• Patients: women aged 40+ should check whether they are due for a mammogram under DHA, DOH Abu Dhabi or MOHAP-aligned guidance.
• Clinics: allocate breast ultrasound and biopsy slots before running corporate screening drives.
• Insurers: check preventive-care benefits, co-pay rules and prior-authorisation triggers for mammography and follow-up imaging.
• Employers: confirm whether screening is free, self-pay or billed through insurance before promoting a workplace event.

For Abu Dhabi payers, Thiqa cardholders can access breast cancer screening services through ADPHC's IFHAS comprehensive screening programme, according to ADPHC. Burjeel's release names Daman as one of the campaign locations, but that does not by itself define insurance coverage. Coverage still depends on the member's policy, medical necessity, network status and plan wording.

What operators should watch next

The commercial signal is simple. Breast screening is moving into workplaces and public locations, while definitive care remains concentrated in licensed oncology centres. Dubai providers under DHA, Abu Dhabi providers under DOH Abu Dhabi and northern emirates providers under MOHAP should treat October campaigns as a capacity test for the rest of the year.

The next question is follow-up leakage. A mobile truck can raise screening volume, but a provider loses clinical and financial value when women with abnormal results fail to book the next test within the recommended timeframe. Operators should track four measures after each campaign: mammograms completed, abnormal findings, time to diagnostic follow-up and oncology referrals accepted.

Patients seeking licensed oncology providers, and clinics checking the competitive map, can use the UAE Open Healthcare Directory to find regulator-licensed oncology and breast-care providers across Dubai, Abu Dhabi, Al Ain and the northern emirates.